Biofidus AG was founded in 2015 to provide fast and reliable solutions to the most complex analytical challenges. With our highly qualified, interdisciplinary team of experts in proteomics, metabolism, stem cells, biochemistry, genetics, and biotechnology, we combine comprehensive analytical knowledge to offer you the best possible platform and guide you through our diverse range of services.

Our portfolio includes a wide array of analytical and bioanalytical services to characterize the structural and functional integrity of your protein biologics (IgGs, ADCs, Nanobodies, Multispecifics etc.) as well as cell and gene therapeutics.

• Mass spectrometric assays

• Surface Plasmon Resonance (SPR)

• Cell-based assays

• NGS-Sequencing (ONT)

• Spectroscopy

• Chromatography

We advise you on the right questions that need to be answered to ensure a rapid and targeted achievement of your milestones.

• Single point of contact

• Holistic analytical portfolio

• Exceptional speed and quality

• Dedicated research teams

As part of the Midas Pharma group our customers get access to commercial‑stage capabilities, including a broad portfolio of GxP‑related services and regulatory expertise.

In biopharma, this translates into integrated, end‑to‑end support from early development through clinical and commercial stages. Services span the supply of starting materials and intermediates as well as comprehensive combination‑product solutions with an innovative device portfolio.

For clinical and commercial phases, Midas Pharma offers a well-established EU pharmaceutical infrastructure that covers EU import and QP batch release, supporting launch readiness through Marketing Authorization Holder (MAH) services, a full pharmacovigilance system with in-house EU-QPPV oversight, and EU wholesale distribution.

Biofidus AG

Guetersloher Str 54

33649, Bielefeld, Germany

www.biofidus.de